age-related-macular-degeneration

Documents about age-related-macular-degeneration

• Palomid 529 in Patients With Neovascular Age-Related Macular Degeneration#829958ClinicalTrials.gov
• Study of Dark Adaptation in Age-Related Macular Degeneration#839407ClinicalTrials.gov
• PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration#1087603ClinicalTrials.gov
• Mechanisms of Retinal Revascularization and Clinical Indicators of Neovascular AMD Relapse#864871ClinicalTrials.gov
• Combination Therapy for Neovascular Age Related Macular Degeneration#1230482ClinicalTrials.gov
• Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration#1030417ClinicalTrials.gov
• Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)#846963ClinicalTrials.gov
• X-82 to Treat Age-related Macular Degeneration#870406ClinicalTrials.gov
• The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration#1184175ClinicalTrials.gov
• Complications of Age-Related Macular Degeneration Prevention Trial#1152559ClinicalTrials.gov
• Device for Age-related Macular Degeneration (AMD)#1364647ClinicalTrials.gov
• 12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)#1398373ClinicalTrials.gov
• Dark Adaptation in Participants With Age-Related Macular Degeneration#1307569ClinicalTrials.gov
• Treatment of Age-Related Macular Degeneration With Anecortave Acetate#1420777ClinicalTrials.gov
• Age-Related Macular Degeneration (AMD) - Usability Study#1385169ClinicalTrials.gov
• Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration#1310657ClinicalTrials.gov
• Neovascular Age-related Macular Degeneration#899492ClinicalTrials.gov
• Safety and Pharmacokinetics of RTH258 in Subjects With Age-Related Macular Degeneration#906886ClinicalTrials.gov
• Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration#1151531ClinicalTrials.gov
• Phase 3 Study of Intravitreal OLN324 in Adults With Neovascular (Wet) Age-related Macular Degeneration (nAMD) (OLN324-CP-04)#876631ClinicalTrials.gov
• LEAP Strategy for Neovascular Age-Related Macular Degeneration#910498ClinicalTrials.gov
• Copaxone in Age Related Macular Degeneration#967990ClinicalTrials.gov
• Connection Between Periodontitis and Exudative Age-related Macular Degeneration#1378837ClinicalTrials.gov
• Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)#917044ClinicalTrials.gov
• Therapy of Age-related Macular Degeneration#1111557ClinicalTrials.gov
• NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration#845848ClinicalTrials.gov
• Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)#1111486ClinicalTrials.gov
• Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration#800604ClinicalTrials.gov
• Lutein for Age-Related Macular Degeneration#1363963ClinicalTrials.gov
• Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration#800185ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of VIS-101 in Participants With Neovascular Age-Related Macular Degeneration#1171961ClinicalTrials.gov
• Macular Neovascularization in Neovascular Age-Related Macular Degeneration#357669IRIS
• Study on Visual Function Impairments in Dry Age-related Macular Degeneration#870677ClinicalTrials.gov
• Recurrent Neovascular Age-related Macular Degeneration After Therapy Suspension#1046933ClinicalTrials.gov
• Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration#979775ClinicalTrials.gov
• Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD#913086ClinicalTrials.gov
• RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)#1320128ClinicalTrials.gov
• Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion#912616ClinicalTrials.gov
• Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)#1421931ClinicalTrials.gov
• Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration#803143ClinicalTrials.gov
• A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration#896032ClinicalTrials.gov
• EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan#1281716ClinicalTrials.gov
• Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)#1322467ClinicalTrials.gov
• Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration#1395932ClinicalTrials.gov
• Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)#806978ClinicalTrials.gov
• Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)#1164213ClinicalTrials.gov
• Resveratrol for Exudative Age-Related Macular Degeneration#1322868ClinicalTrials.gov
• Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting#979487ClinicalTrials.gov
• Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)#1150177ClinicalTrials.gov
• Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy#1338192ClinicalTrials.gov